Press coverage about Tivity Health (NASDAQ:TVTY) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tivity Health earned a news impact score of 0.18 on Accern’s scale. Accern also gave news coverage about the company an impact score of 43.0716888455452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Tivity Health (TVTY) traded up $0.60 during trading on Friday, reaching $36.80. 417,938 shares of the company traded hands, compared to its average volume of 348,648. The company has a market cap of $1,457.91, a P/E ratio of 22.44, a P/E/G ratio of 1.90 and a beta of 0.25. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.60 and a quick ratio of 0.60. Tivity Health has a one year low of $26.20 and a one year high of $48.50.
TVTY has been the subject of a number of recent research reports. Chardan Capital reissued a “neutral” rating and set a $44.00 price objective (up previously from $40.00) on shares of Tivity Health in a research report on Friday, October 27th. SunTrust Banks set a $50.00 price objective on shares of Tivity Health and gave the company a “buy” rating in a research report on Friday, October 27th. Zacks Investment Research raised shares of Tivity Health from a “hold” rating to a “buy” rating and set a $52.00 price objective for the company in a research report on Tuesday, October 31st. Oppenheimer upped their target price on shares of Tivity Health from $47.00 to $50.00 and gave the stock an “outperform” rating in a report on Wednesday, November 1st. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $45.00 target price on shares of Tivity Health in a report on Monday, November 6th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Tivity Health has a consensus rating of “Buy” and an average price target of $45.25.
In related news, Director Conan Laughlin sold 115,087 shares of the company’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $33.87, for a total value of $3,897,996.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 745,087 shares of company stock valued at $25,610,597 in the last ninety days. 8.42% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Tivity Health (NASDAQ:TVTY) Stock Price” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://ledgergazette.com/2018/02/12/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-tivity-health-tvty-share-price.html.
About Tivity Health
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.